127 related articles for article (PubMed ID: 27089657)
1. [Pre-Thrombotic (Hypercoagulable) State/Hypercoagulable Disease].
Wada H
Rinsho Byori; 2015 Dec; 63(12):1405-11. PubMed ID: 27089657
[TBL] [Abstract][Full Text] [Related]
2. Are fibrin-related markers useful for the diagnosis of thrombosis?
Wada H; Sakuragawa N
Semin Thromb Hemost; 2008 Feb; 34(1):33-8. PubMed ID: 18393141
[TBL] [Abstract][Full Text] [Related]
3. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
4. Plasma Soluble Fibrin Is Useful for the Diagnosis of Thrombotic Diseases.
Ezaki M; Wada H; Ichikawa Y; Ikeda N; Shiraki K; Yamamoto A; Moritani I; Shimaoka M; Shimpo H
J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048680
[TBL] [Abstract][Full Text] [Related]
5. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
Dempfle CE
Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
[TBL] [Abstract][Full Text] [Related]
6. The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery.
Hasegawa M; Wada H; Wakabayashi H; Yoshida K; Miyamoto N; Asanuma K; Matsumoto T; Ohishi K; Shimokariya Y; Yamada N; Uchida A; Sudo A
Clin Chim Acta; 2013 Oct; 425():109-13. PubMed ID: 23876378
[TBL] [Abstract][Full Text] [Related]
7. Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis.
Ieko M; Nakabayashi T; Tarumi T; Naito S; Yoshida M; Kanazawa K; Mizukami K; Koike T
Clin Chim Acta; 2007; 386(1-2):38-45. PubMed ID: 17803984
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of thrombosis by hemostatic markers].
Wada H; Matsumoto T; Yamashita Y
Nihon Rinsho; 2014 Jul; 72(7):1232-6. PubMed ID: 25163313
[TBL] [Abstract][Full Text] [Related]
9. Soluble fibrin monomer complex levels during oral anticoagulant therapy do not predict subsequent thromboembolic events in patients with permanent atrial fibrillation.
Sadanaga T; Mitamura H
Int J Cardiol; 2013 Sep; 168(1):578-80. PubMed ID: 23465239
[No Abstract] [Full Text] [Related]
10. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
11. D-dimer kit with a High FDP/D-Dimer Ratio is Useful for Diagnosing Thrombotic Diseases.
Ikeda N; Wada H; Ichikawa Y; Ezaki M; Tanaka M; Hiromori S; Shiraki K; Moritani I; Yamamoto A; Shimpo H; Shimaoka M
Clin Appl Thromb Hemost; 2022; 28():10760296211070584. PubMed ID: 34994210
[TBL] [Abstract][Full Text] [Related]
12. Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events.
Lowe GD; Rumley A
Thromb Haemost; 1999 Aug; 82(2):667-72. PubMed ID: 10605766
[No Abstract] [Full Text] [Related]
13. Effect of hyperthyroidism on the hypercoagulable state and thromboembolic events in patients with atrial fibrillation.
Chen Q; Yan Y; Zhang L; Cheng K; Liu Y; Zhu W
Cardiology; 2014; 127(3):176-82. PubMed ID: 24434544
[TBL] [Abstract][Full Text] [Related]
14. Tests of fibrin metabolism in recurrent venous thromboembolism.
Bynum LJ; Parkey RW; Wilson JE
Arch Intern Med; 1977 Oct; 137(10):1385-9. PubMed ID: 921420
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children.
Goldenberg NA; Knapp-Clevenger R; Manco-Johnson MJ;
N Engl J Med; 2004 Sep; 351(11):1081-8. PubMed ID: 15356305
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the cutoff values in fibrin-related markers for the diagnosis of overt DIC.
Hatada T; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Kushimoto S; Seki Y; Okamura T; Imai H; Kaneko T; Nobori T;
Clin Appl Thromb Hemost; 2012 Sep; 18(5):495-500. PubMed ID: 22203032
[TBL] [Abstract][Full Text] [Related]
17. Hypercoagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence.
Danese E; Montagnana M; Cervellin G; Lippi G
Ann Med; 2014 Sep; 46(6):364-71. PubMed ID: 24863960
[TBL] [Abstract][Full Text] [Related]
18. [A test for the detection of fibrin in the plasma].
Franke M; Hafter R; von Hugo R; Röbl M; Graeff H
Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):105-9. PubMed ID: 3956964
[TBL] [Abstract][Full Text] [Related]
19. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
20. D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications.
Samama MM; Horellou MH; Elalamy I; Mathieux V; Ombandza-Moussa E; Conard J
Semin Vasc Med; 2005 Nov; 5(4):371-4. PubMed ID: 16302158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
